TriangleNCT02722668 · OUTCOME
Neutrophil Engraftment
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- Percentage of participants
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- Day 42
What was measured
Percentage of subjects with neutrophil engraftment.
Groups in this outcome
No Anti-thymocyte Globulin (ATG)
Hematologic malignancy patients who have received a previous autologous transplant or ≥ 2 cycles of multi-agent chemotherapy within the 3 months previous to umbilical cord blood transplantation.
Anti-thymocyte Globulin (ATG)
Hematologic malignancy patients who have not been treated with prior autologous transplant or ≤ 1 cycle of chemotherapy in the 3 months previous to umbilical cord blood transplantation, should receive Anti-thymocyte Globulin (ATG) as part of their conditioning regimen.
| Group | Source count |
|---|---|
| No Anti-thymocyte Globulin (ATG) | 5 |
| Anti-thymocyte Globulin (ATG) | 10 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| No Anti-thymocyte Globulin (ATG) | 80 | Not reported | 42 | 99 | Not reported |
| Anti-thymocyte Globulin (ATG) | 90 | Not reported | 64 | 99 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 42
- upper Limit
- 99
- value
- 80
- group Id
- OG001
- lower Limit
- 64
- upper Limit
- 99
- value
- 90
- denoms
- counts
- group Id
- OG000
- value
- 5
- group Id
- OG001
- value
- 10
- units
- Participants
- description
- Percentage of subjects with neutrophil engraftment.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Hematologic malignancy patients who have received a previous autologous transplant or ≥ 2 cycles of multi-agent chemotherapy within the 3 months previous to umbilical cord blood transplantation.
- id
- OG000
- title
- No Anti-thymocyte Globulin (ATG)
- description
- Hematologic malignancy patients who have not been treated with prior autologous transplant or ≤ 1 cycle of chemotherapy in the 3 months previous to umbilical cord blood transplantation, should receive Anti-thymocyte Globulin (ATG) as part of their conditioning regimen.
- id
- OG001
- title
- Anti-thymocyte Globulin (ATG)
- param Type
- NUMBER
- reporting Status
- POSTED
- time Frame
- Day 42
- title
- Neutrophil Engraftment
- type
- SECONDARY
- unit Of Measure
- Percentage of participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice